Accelerate Diagnostics, Inc. Overview
Pro stress-test →Accelerate Diagnostics is an in vitro diagnostics company that provides solutions for the rapid diagnosis of serious infections through developing and commercializing innovative instrumentation for the identification and antibiotic susceptibility testing of infectious pathogens. The company's flagship platforms address critical clinical needs in sepsis management and antibiotic stewardship.
Strategic Profile
Pro stress-test →The company sells products directly and through third-party distributors to hospital microbiology laboratories domestically and internationally. Clinical data demonstrates significant clinical outcomes, including a statistically significant reduction in 30-day mortality for patients receiving faster diagnostic results.
Competitive Landscape
Pro stress-test →Accelerate Diagnostics competes in the rapid microbial diagnostics space against established clinical laboratory platforms. Main competitors include companies offering traditional blood culture systems and newer molecular diagnostics platforms. The company's differentiation lies in its speed of pathogen identification and antibiotic susceptibility testing, critical for sepsis management.
Industry Context
Accelerate Diagnostics, Inc. operates in In Vitro Diagnostics / Infectious Disease Testing.
Key facts
Founded: 1982 · Headquarters: Tucson, US · Employees: 107 · Revenue: $11.69M TTM (January 2026) · Market cap: $860K